🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, single-center, interventional, dose-escalation clinic...
Status
Unknown
Location
Anhui Provincial Hospital
Start Date
2023-09-27
Trial ID
NCT06056752
Treatments Being Tested
Idiopathic nephrotic syndrome is steroid-sensitive in more than 90% of case...
Status
Completed
Location
Robert Debre Hospital, AP-HP
Start Date
2010-09
Trial ID
NCT01092962
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
Background: CGD causes infections and inflammation. The only cure currentl...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-10-28
Trial ID
NCT03910452
This is a prospective, randomized, open-label, multicenter phase III study ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-06-02
Trial ID
NCT06996093
GATLA 8-AML´07 trial is an multicenter phase III dose-optimization trial fo...
Status
Completed
Location
Multiple Locations
Start Date
2007-08-01
Trial ID
NCT06211452
Treatments Being Tested
The effect of anti-tumor treatment is not satisfying in HBV-related hepatoc...
Status
Completed
Location
The Third Affiliated Hospital of Sun Yat-sen University
Start Date
2017-05-01
Trial ID
NCT03086564
Treatments Being Tested
This example study evaluates the safety, tolerability, and preliminary anti...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07627711
This multicenter phase 1 trial with "3 + 3" dose escalation design seeks to...
Status
Recruiting
Location
University of Kansas Cancer Center
Start Date
2025-03-31
Trial ID
NCT06879340
Treatments Being Tested
This study will examine the safety and efficacy of pembrolizumab (MK-3475) ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama ( Site 0023)
Start Date
2018-04-09
Trial ID
NCT03407144